| Inventor | Institute |
|---|---|
| Anne-Marie Mes-Masson and Diane Provencher | Centre Hospitalier de L’université de Montréal |
| SKU: | 161899 |
|---|---|
| Product description: | Derived from solid tumor of patient diagnosed with high-grade serous ovarian cancer taken pre-chemotherapy from primary disease. This cell line also formed tumors at subcutaneous sites in SCID mice. Three other cell lines from this patient are available and take at different distinct time points throughout treatment offering possible insights into the mechanisms of tumor progression and evolution. |
| CRISPR: | No |
| Production details: | Solid ovarian tumor derived cell line was established using the scrape method where tumor tissue was scraped into a 100mm plate with complete OSE medium and maintained for 40 days. Medium was replaced weekly. |
| Cellosaurus ID: | CVCL_9T19 |
| Disease: | Cancer |
| Cat. #: | 161899 |
|---|---|
| Cancer types: | Ovarian cancer |
| Research Fields: | Cancer |
| Organism: | Human |
| Tissue: | Ovary |
| Morphology: | Was able to form semi-compact spheroids |
| Growth properties: | Mixed |
| Primary citation: | Létourneau, et al. 2012. BMC Cancer. 29,12:379. PMID: 22931248 |
| Format: | Frozen |
|---|---|
| Storage conditions: | Liquid Nitrogen |
| Shipping conditions: | Dry Ice |
| Growth medium: | OSE medium, 10% FBS, 0.5ug/ml apmphotericin B and 50ug/ml gentamycin sulfate |
| Temperature: | 37° C |
| Atmosphere: | 5% O2 and 5% CO2 |
| Biosafety level: | 1 |
| References: |
Asare-Werehene, et al. 2023. Cancers (Basel). 30,15(9):2566. PMID: 37174032 Vias, et al. 2023. Elife. 11,12:e83867. PMID: 37166279 Tomas, et al. 2023. J Ovarian Res. 11, 16(1):70. PMID: 37038202 Létourneau, et al. 2012. BMC Cancer. 29,12:379. PMID: 22931248 |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.